Direct Evidence that Bevacizumab, an Anti-VEGF Antibody, Up-regulates SDF1 , CXCR4, CXCL6, and Neuropilin 1 in Tumors from Patients with Rectal Cancer

出版年份 2009 全文链接

标题

作者

关键词

出版物

CANCER RESEARCH

Volume 69, Issue 20, Pages 7905-7910

出版商

American Association for Cancer Research (AACR)

发表日期

2009-10-15

DOI

10.1158/0008-5472.can-09-2099

向作者/读者发起求助以获取更多资源

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

CANCER RESEARCH

向作者/读者发起求助以获取更多资源

Protocol

Reagent

Reprint

Find Funding. Review Successful Grants.

Create your own webinar